KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

NovoCure (NVCR) Inventory Average (2016 - 2026)

NovoCure's Inventory Average history spans 12 years, with the latest figure at $42.3 million for Q1 2026.

  • On a quarterly basis, Inventory Average rose 13.43% to $42.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was $42.3 million, a 13.43% increase, with the full-year FY2025 number at $38.1 million, up 4.04% from a year prior.
  • Inventory Average hit $42.3 million in Q1 2026 for NovoCure, up from $40.1 million in the prior quarter.
  • Over the last five years, Inventory Average for NVCR hit a ceiling of $42.3 million in Q1 2026 and a floor of $26.8 million in Q1 2022.
  • Historically, Inventory Average has averaged $35.6 million across 5 years, with a median of $37.3 million in 2025.
  • Biggest five-year swings in Inventory Average: surged 33.45% in 2023 and later fell 7.44% in 2025.
  • Tracing NVCR's Inventory Average over 5 years: stood at $28.1 million in 2022, then surged by 33.45% to $37.5 million in 2023, then fell by 1.04% to $37.1 million in 2024, then rose by 8.13% to $40.1 million in 2025, then grew by 5.43% to $42.3 million in 2026.
  • Business Quant data shows Inventory Average for NVCR at $42.3 million in Q1 2026, $40.1 million in Q4 2025, and $39.7 million in Q3 2025.